出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2024年3月
Probiotics Market – Global Forecast to 2029
プロバイオティクス市場 : 製品タイプ [機能性食品&飲料 (FnB)、栄養補助食品、飼料]、原材料 (細菌&酵母)、エンドユーザー (人間&動物)、流通チャネル&地域別 – 2029年までの世界予測
Probiotics Market by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region – Global Forecast to 2029
ページ数 | 342 |
図表数 | 353 |
価格 | |
シングルユーザライセンス | USD 4,950 |
マルチユーザライセンス(5名) | USD 6,650 |
コーポレート(サイト)ライセンス | USD 8,150 |
エンタープライズライセンス | USD 10,000 |
種別 | 英文調査報告書 |
Report Overview
According to MarketsandMarkets, the Probiotics market is projected to reach USD 105.7 billion by 2029 from USD 71.2 billion by 2024, at a CAGR of 8.2% during the forecast period in terms of value.
MarketsandMarkets によると、プロバイオティクス市場は、予測期間中に 8.2% の CAGR で、2024 年までに 712 億米ドルから 2029 年までに 1,057 億米ドルに達すると予測されています。
Dietary supplements present consumers with a straightforward and hassle-free means to integrate probiotics into their daily regimen. With formats ranging from tablets to capsules and chewable, these supplements require no preparation and can be easily stored at room temperature, catering to the demands of modern, fast-paced lifestyles. This convenience factor resonates strongly with busy individuals seeking an effortless solution to bolster gut health, thereby driving sustained demand for dietary probiotic supplements.
Moreover, the appeal of dietary supplements extends beyond convenience to encompass precise dosing capabilities, allowing consumers to tailor their probiotic intake to address specific health concerns. Through targeted formulations containing distinct probiotic strains, consumers can effectively manage digestive health, support immune function, and even promote mental well-being. The realm of dietary supplements further thrives on innovation, with personalized formulations combining probiotics with complementary ingredients such as prebiotics or vitamins gaining traction.
Additionally, emerging advancements such as chewable tablets and timed-release capsules enhance consumer choice and efficacy, positioning dietary supplements as a cornerstone of proactive health management within the evolving probiotics market landscape.
” By distribution channel, Online is estimated to grow with the highest CAGR during the forecast period.”
Online channels are poised to experience significant growth in the distribution of probiotics, outpacing traditional brick-and-mortar outlets. According to data from the U.S. Food and Drug Administration (FDA) released in October 2022, online sales of dietary supplements, including probiotics, have witnessed a substantial surge, particularly among younger demographics. This trend is propelled by several factors, including the unparalleled convenience offered by online retailers, allowing consumers to browse and purchase probiotics from the comfort of their homes at any time, thus eliminating the need for physical store visits.
Moreover, e-commerce platforms boast a wider product selection compared to traditional stores, offering diverse probiotic brands, formulations, and international options, catering to varied consumer preferences. This shift towards online channels is further reinforced by government initiatives such as India’s Digital India program, which aims to facilitate safe and secure online transactions for health and wellness products, including probiotics.
Furthermore, subscription models and personalized recommendations offered by online retailers enhance consumer engagement and loyalty. Consumers can opt for subscription services for recurring probiotic deliveries, ensuring a steady supply of products. Advanced e-commerce platforms leverage user data to provide personalized recommendations tailored to individual needs and health goals
“Europe will significantly contribute towards market growth during the forecast period.”
Europe is positioned as a pivotal contributor to the burgeoning probiotics market throughout the forecasted period. Spearheaded by prominent industry leaders such as Probi (Sweden), Nestlé (Switzerland), AB-Biotics, S.A. (Belgium), Danone (France), BioGaia (Sweden), and Adisseo (France) with headquarters and robust market presence in the region, Europe stands as a stronghold of innovation and consumer engagement. For instance, in December 2023 Eurobarometer survey conducted by the European Commission highlighted a burgeoning understanding of the gut microbiome’s pivotal role in overall well-being. This heightened awareness translates into a surging demand for diverse probiotic products, spanning from digestive health aids to immune-boosting supplements and solutions for mental well-being, thus fueling market expansion.
Moreover, Europe benefits from a supportive regulatory landscape established by the European Union (EU), mandating stringent scientific substantiation of health claims associated with probiotics. This regulatory rigor ensures a level of quality and transparency within the market, bolstering consumer confidence and fostering sustained market growth.
Break-up of Primaries:
By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%
By Designation: C-level-45%, D-level – 33%, and Others- 22%
By Region: North America – 15%, Europe – 20%, Asia Pacific – 40%, South America-12%, RoW – 13%,
Others include sales managers, territory managers, and product managers.
Leading players profiled in this report:
• Probi (Sweden)
• Nestlé (Switzerland)
• ADM (US)
• Danone (France)
• International Flavors & Fragrances Inc. (US)
• Yakult Honsha Co., Ltd. (Japan)
• BioGaia (Sweden)
• MORINAGA MILK INDUSTRY CO., LTD. (Japan)
• Meiji Holdings Co., Ltd. (Japan)
• Lifeway Foods, Inc. (US)
• Adisseo (France)
• Winclove Probiotics (US)
• AB-Biotics, S.A. (Belgium)
• Apsen Farmacêutica (Brazil)
• Lallemand (Canada)
• Elanco (US)
• NextFoods, Inc.(US)
• i-Health, Inc. (US)
• Suja Life LLC. (US)
• Renew Life Formulas LLC. (US)
• BIOHM Health (US)
• Sun Genomics (US)
• Unique Biotech Ltd (India)
• So Good So You (US)
• Protocol For Life Balance (US)
The study includes an in-depth competitive analysis of these key players in the Probiotics market with their company profiles, recent developments, and key market strategies.
Research Coverage:
The report segments the Probiotics market on the basis of product type, ingredient, distribution channel, end user, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global Probiotics market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall probiotics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Health benefits associated with probiotic-fortified foods), restraints (High R&D costs for developing new probiotic strains), opportunities (Replacement of pharmaceutical agents by probiotics), and challenges (Complexities in integrating probiotics in functional foods) influencing the growth of the Probiotics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Probiotics market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the Probiotics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Probiotics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), and Yakult Honsha Co., Ltd. (Japan), among others in the Probiotics market strategies. The report also helps stakeholders understand the Probiotics market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 39
1.3 STUDY SCOPE 39
1.3.1 MARKET SEGMENTATION 39
FIGURE 1 PROBIOTICS MARKET SEGMENTATION 39
1.3.2 INCLUSIONS AND EXCLUSIONS 40
1.3.3 REGIONS COVERED 41
FIGURE 2 PROBIOTICS MARKET SEGMENTATION, BY REGION 41
1.3.4 YEARS CONSIDERED 41
FIGURE 3 STUDY PERIODS CONSIDERED 41
1.4 UNITS CONSIDERED 42
1.4.1 CURRENCY (VALUE UNIT) 42
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019–2022 42
1.4.2 VOLUME UNIT 43
1.5 STAKEHOLDERS 43
1.6 SUMMARY OF CHANGES 44
1.7 RECESSION IMPACT ANALYSIS 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 4 PROBIOTICS MARKET: RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 46
FIGURE 5 KEY DATA FROM SECONDARY SOURCES 46
2.1.2 PRIMARY DATA 47
2.1.2.1 Key primary insights 47
FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES 47
2.1.2.2 Breakdown of Primary Interviews 48
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION 49
2.2.1 BOTTOM-UP APPROACH 49
FIGURE 8 PROBIOTICS MARKET: BOTTOM-UP APPROACH 50
2.2.2 TOP-DOWN APPROACH 50
2.2.2.1 Supply side analysis 51
FIGURE 9 PROBIOTICS MARKET SIZE CALCULATION STEPS AND THEIR CORRESPONDING SOURCES: SUPPLY SIDE 51
FIGURE 10 PROBIOTICS MARKET: TOP-DOWN APPROACH 52
2.3 DATA TRIANGULATION 53
FIGURE 11 DATA TRIANGULATION 53
2.4 RESEARCH ASSUMPTIONS 54
2.5 RESEARCH LIMITATIONS 54
FIGURE 12 RESEARCH LIMITATIONS & ASSOCIATED RISKS 54
2.6 RECESSION IMPACT ON PROBIOTICS MARKET 55
2.6.1 RECESSION MACROECONOMIC INDICATORS 55
FIGURE 13 INDICATORS OF RECESSION 55
FIGURE 14 GLOBAL INFLATION RATE, 2011–2022 56
FIGURE 15 GLOBAL GDP, 2011–2022 (USD TRILLION) 57
FIGURE 16 RECESSION INDICATORS AND THEIR IMPACT ON PROBIOTICS MARKET 58
FIGURE 17 PROBIOTICS MARKET: EARLIER FORECAST VS RECESSION IMPACT FORECAST, 2024 58
3 EXECUTIVE SUMMARY 60
TABLE 2 PROBIOTICS MARKET SNAPSHOT, 2024 VS. 2029 61
FIGURE 18 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION) 62
FIGURE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION) 62
FIGURE 20 PROBIOTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION) 63
FIGURE 21 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION) 63
FIGURE 22 PROBIOTICS MARKET SHARE (VALUE), BY REGION, 2023 64
4 PREMIUM INSIGHTS 65
4.1 ATTRACTIVE OPPORTUNITIES IN PROBIOTICS MARKET 65
FIGURE 23 HEALTH BENEFITS ASSOCIATED WITH PROBIOTIC-FORTIFIED FOODS & BEVERAGES TO PROPEL MARKET 65
4.2 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE AND COUNTRY 66
FIGURE 24 CHINA AND FUNCTIONAL FOOD & BEVERAGES TO ACCOUNT FOR LARGEST SEGMENTAL SHARES IN ASIA PACIFIC PROBIOTICS MARKET IN 2023 66
4.3 PROBIOTICS MARKET, BY PRODUCT TYPE 66
FIGURE 25 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO DOMINATE AMONG PROBIOTIC PRODUCT TYPES IN MARKET DURING FORECAST PERIOD 66
4.4 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY-PRODUCT SUBTYPE 67
FIGURE 26 DAIRY PRODUCTS TO HAVE SUBSTANTIAL LEAD OVER OTHER FUNCTIONAL FOOD & BEVERAGES WITH PROBIOTICS DURING FORECAST PERIOD 67
4.5 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL 67
FIGURE 27 HYPERMARKETS & SUPERMARKETS TO BE LEADING DISTRIBUTION CHANNELS OF PROBIOTICS DURING FORECAST PERIOD 67
4.6 PROBIOTICS MARKET, BY END USER 68
FIGURE 28 HUMAN END USE TO COMMAND LION’S SHARE OVER ANIMAL END USE OF PROBIOTICS DURING STUDY PERIOD 68
4.7 PROBIOTICS MARKET, BY INGREDIENT 68
FIGURE 29 BACTERIAL PROBIOTICS TO DOMINATE MARKET DURING FORECAST PERIOD 68
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INCREASE IN RETAIL SALES 69
FIGURE 30 US: RETAIL AND FOOD SERVICE SALES, 2016–2022 (USD BILLION) 70
5.2.2 GROWTH OPPORTUNITIES IN DEVELOPING REGIONS SUCH AS ASIA PACIFIC AND SOUTH AMERICA 70
FIGURE 31 ASIA: ANNUAL GDP GROWTH RATE, BY COUNTRY, 2022 71
5.3 MARKET DYNAMICS 71
FIGURE 32 MARKET DYNAMICS 71
5.3.1 DRIVERS 72
5.3.1.1 Rise in awareness on health benefits associated with probiotic-fortified foods 72
5.3.1.2 Participation of international bodies in R&D of probiotic products 72
5.3.1.3 Technological advancements in probiotic products 73
5.3.2 RESTRAINTS 73
5.3.2.1 High R&D costs for developing new probiotic strains 73
5.3.2.2 Instances of allergic reactions to some probiotic supplements 74
5.3.2.3 Stress factors affecting probiotic efficacy 74
5.3.3 OPPORTUNITIES 74
5.3.3.1 Ban on use of Antibiotic Growth Promoters (AGPs) in feed in EU 74
5.3.3.2 Replacement of pharmaceutical agents by probiotics 75
5.3.3.3 Use of yeast probiotics as antibiotics or growth promoters 75
5.3.4 CHALLENGES 76
5.3.4.1 Complexities in integrating probiotics in functional foods 76
5.3.4.2 Intolerance of probiotics to stomach acid and bile 76
6 INDUSTRY TRENDS 77
6.1 INTRODUCTION 77
6.2 VALUE CHAIN ANALYSIS 77
FIGURE 33 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET 78
6.2.1 RESEARCH & PRODUCT DEVELOPMENT 78
6.2.2 SOURCING 78
6.2.3 PRODUCTION & PROCESSING 79
6.2.4 PACKAGING & STORAGE 79
6.2.5 DISTRIBUTION, SALES, AND MARKETING 79
6.3 SUPPLY CHAIN ANALYSIS 79
FIGURE 34 SUPPLY CHAIN ANALYSIS OF PROBIOTICS MARKET 79
6.4 TECHNOLOGY ANALYSIS 80
6.4.1 KEY TECHNOLOGIES 80
6.4.1.1 Multi-layer embedding 80
6.4.1.2 Microencapsulated powder for probiotication in food products 81
6.4.2 COMPLEMENTARY TECHNOLOGY 81
6.4.2.1 Probiotics and artificial intelligence 81
6.5 PRICING ANALYSIS 81
6.5.1 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGES 81
TABLE 3 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGE PRODUCT, 2024 (USD/TON) 82
6.5.2 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE 82
FIGURE 35 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2022–2024 (USD/TON) 82
FIGURE 36 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2021-2024 (USD/TON) 83
TABLE 4 AVERAGE SELLING PRICE TRENDS FOR FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2024 (USD/TON) 83
TABLE 5 AVERAGE SELLING PRICE TRENDS FOR DIETARY SUPPLEMENTS, BY REGION, 2022–2024 (USD/TON) 83
TABLE 6 AVERAGE SELLING PRICE TRENDS FOR FEED, BY REGION, 2022–2024 (USD/TON) 84
6.6 ECOSYSTEM ANALYSIS/MARKET MAP 84
6.6.1 SUPPLY-SIDE ANALYSIS 84
6.6.2 DEMAND SIDE ANALYSIS 84
FIGURE 37 PROBIOTICS MARKET MAPPING 85
FIGURE 38 ECOSYSTEM MAPPING OF PROBIOTICS MARKET 85
TABLE 7 PROBIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM) 86
6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 87
FIGURE 39 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 87
6.8 TRADE DATA ANALYSIS 88
TABLE 8 EXPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG) 88
TABLE 9 IMPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG) 88
6.9 PATENT ANALYSIS 89
FIGURE 40 NUMBER OF PATENTS GRANTED BETWEEN 2013 AND 2023 89
FIGURE 41 TOP 10 INVENTORS WITH HIGHEST NUMBER OF PATENT DOCUMENTS 90
TABLE 10 KEY PATENTS IN PROBIOTICS MARKET, 2023–2024 91
6.10 KEY CONFERENCES & EVENTS 93
6.11 REGULATORY LANDSCAPE 94
6.11.1 PERTINENT REGULATORY FACTORS 94
6.11.1.1 North america 94
6.11.1.1.1 US 94
6.11.1.1.2 Canada 94
6.11.1.2 Europe 95
6.11.1.3 Asia pacific 95
6.11.1.3.1 Japan 95
6.11.1.3.2 Australia and New Zealand 96
6.11.1.3.3 India 96
6.11.1.4 South america 97
6.11.1.4.1 Brazil 97
6.11.1.5 Row 97
6.11.1.5.1 Middle East 97
6.11.1.5.2 Africa (South Africa) 97
6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 98
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
6.12 PORTER’S FIVE FORCES ANALYSIS 99
TABLE 15 PROBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 99
6.12.1 THREAT OF NEW ENTRANTS 100
6.12.2 THREAT OF SUBSTITUTES 100
6.12.3 BARGAINING POWER OF SUPPLIERS 100
6.12.4 BARGAINING POWER OF BUYERS 100
6.12.5 INTENSITY OF COMPETITIVE RIVALRY 101
6.13 CASE STUDIES 101
6.13.1 ADM: PROMOTED METABOLIC HEALTH WITH BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 BPL1 101
6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH: PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING 101
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 102
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
FIGURE 42 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR KEY PRODUCT TYPE 102
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE PRODUCT TYPES 102
6.14.2 BUYING CRITERIA 103
TABLE 17 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE 103
FIGURE 43 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE 103
6.15 INVESTMENT AND FUNDING SCENARIO 104
FIGURE 44 INVESTMENT AND FUNDING SCENARIO 104
7 PROBIOTICS MARKET, BY PRODUCT TYPE 105
7.1 INTRODUCTION 106
FIGURE 45 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION) 106
TABLE 18 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 107
TABLE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 107
TABLE 20 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 107
TABLE 21 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 108
7.2 FUNCTIONAL FOOD & BEVERAGES 108
FIGURE 46 US: PREFERRED SOURCES OF PROBIOTICS CONSUMPTION, 2022 109
TABLE 22 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (USD BILLION) 109
TABLE 23 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (USD BILLION) 110
TABLE 24 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (KT) 110
TABLE 25 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (KT) 110
TABLE 26 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 111
TABLE 27 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 111
7.2.1 DAIRY PRODUCTS 111
7.2.1.1 Popularity of dairy products and high compatibility with probiotics 111
7.2.2 NONDAIRY BEVERAGES 112
7.2.2.1 Need to cater to increasing lactose-intolerant consumers 112
7.2.3 INFANT FORMULA 112
7.2.3.1 Rise in consumption of fortified infant nutrition 112
7.2.4 CEREALS 113
7.2.4.1 Rise in demand for ready-to-eat food items with changing consumer lifestyles 113
7.2.5 OTHER FUNCTIONAL FOOD & BEVERAGES 113
7.3 DIETARY SUPPLEMENTS 114
TABLE 28 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (USD BILLION) 114
TABLE 29 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (USD BILLION) 115
TABLE 30 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (KT) 115
TABLE 31 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (KT) 115
TABLE 32 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 116
TABLE 33 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 116
7.3.1 TABLETS 116
7.3.1.1 High shelf-life, affordability, and wide range of dosage patterns 116
7.3.2 CAPSULES 117
7.3.2.1 Rapid absorption of nutrients and highly customizable 117
7.3.3 POWDERS 117
7.3.3.1 Easy release of active ingredients and high stability 117
7.3.4 LIQUIDS 118
7.3.4.1 Easy consumption, greater homogeneity, and high absorption in bloodstreams 118
7.3.5 SOFT GELS 118
7.3.5.1 Relatively low cost and improved bioavailability 118
7.3.6 GEL CAPS 119
7.3.6.1 Pure-protein, benign oral dosage form 119
7.4 FEED 119
7.4.1 RISE IN TREND FOR PROVIDING PETS WITH HIGH-QUALITY AND HEALTHY WET AND DRY MEALS 119
TABLE 34 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (USD BILLION) 120
TABLE 35 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (USD BILLION) 120
TABLE 36 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (KT) 121
TABLE 37 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (KT) 121
8 PROBIOTICS MARKET, BY INGREDIENT 122
8.1 INTRODUCTION 123
TABLE 38 DIVERSITY OF PROBIOTICS 123
TABLE 39 HEALTH BENEFITS OF PROBIOTIC MICROORGANISMS 124
FIGURE 47 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION) 126
TABLE 40 PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 127
TABLE 41 PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 127
8.2 BACTERIA 127
TABLE 42 BACTERIAL PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 128
TABLE 43 BACTERIAL PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 128
TABLE 44 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION) 128
TABLE 45 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION) 128
8.2.1 LACTOBACILLI 129
8.2.1.1 Lactobacillus acidophilus 129
8.2.1.1.1 Rise in consumption of fermented foods, cheese, and yogurt 129
8.2.1.2 Lactobacillus rhamnosus 129
8.2.1.2.1 Ability to endure harsh gut conditions and reduced risk of antibiotic-associated intestinal symptoms 129
8.2.1.3 Lactobacillus casei 130
8.2.1.3.1 Broad-spectrum action against diseases caused by gastrointestinal pathogenic bacteria 130
8.2.1.4 Lactobacillus reuteri 130
8.2.1.4.1 Opportunities in preventive and therapeutic avenues against inflammatory diseases 130
8.2.2 BIFIDOBACTERIUM 131
8.2.2.1 Benefits against chronic ailments, especially in infant gut health 131
8.2.3 STREPTOCOCCUS THERMOPHILUS 131
8.2.3.1 Growing application of Streptococcus thermophilus in food and feed industries 131
8.3 YEAST 132
TABLE 46 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 133
TABLE 47 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 133
TABLE 48 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION) 133
TABLE 49 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION) 133
TABLE 50 BENEFICIAL EFFECTS OF YEAST 134
8.3.1 SACCHAROMYCES BOULARDII 135
8.3.1.1 GI stress-resistance key in maintaining gut flora balance 135
8.3.2 OTHER YEASTS 135
9 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL 136
9.1 INTRODUCTION 137
FIGURE 48 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION) 137
TABLE 51 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 137
TABLE 52 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 138
9.2 HYPERMARKETS/SUPERMARKETS 138
9.2.1 EXPANSION OF SUPERMARKETS IN ASIA PACIFIC 138
TABLE 53 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2020–2023 (USD BILLION) 139
TABLE 54 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2024–2029 (USD BILLION) 139
9.3 PHARMACIES/DRUGSTORES 139
9.3.1 RISE IN AWARENESS FOR PROBIOTIC SUPPLEMENTS IN DEVELOPED COUNTRIES TO POPULARIZE PHARMACIES 139
TABLE 55 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2020–2023 (USD BILLION) 140
TABLE 56 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2024–2029 (USD BILLION) 140
9.4 SPECIALTY STORES 141
9.4.1 PROBIOTIC SALES FUELED BY PROPER STORAGE AND TRANSPARENT LABELING 141
TABLE 57 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2020–2023 (USD BILLION) 141
TABLE 58 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2024–2029 (USD BILLION) 141
9.5 ONLINE 142
9.5.1 ONLINE SALES SURGE DUE TO CONVENIENCE, HEALTH FOCUS, AND STRONG BRAND LOYALTY AMONG CONSUMERS 142
TABLE 59 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2020–2023 (USD BILLION) 142
TABLE 60 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2024–2029 (USD BILLION) 142
9.6 CONVENIENCE STORES/SMALL RETAIL FORMATS 143
9.6.1 EASY ACCESS FOR CONSUMERS ENCOURAGING PURCHASE 143
TABLE 61 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2020–2023 (USD BILLION) 143
TABLE 62 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2024–2029 (USD BILLION) 143
10 PROBIOTICS MARKET, BY END USER 144
10.1 INTRODUCTION 145
FIGURE 49 HUMAN CONSUMPTION TO DOMINATE MARKET FROM 2024 TO 2029 (USD BILLION) 145
TABLE 63 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 146
TABLE 64 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 146
10.2 HUMAN 146
10.2.1 RISING TREND OF CONSUMING FUNCTIONAL FOODS DUE TO HEALTH CONSCIOUSNESS 146
FIGURE 50 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS 147
TABLE 65 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2020–2023 (USD BILLION) 147
TABLE 66 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2024–2029 (USD BILLION) 148
10.3 ANIMAL 148
10.3.1 BAN ON SYNTHETIC ANTIBIOTICS TO BOOST MARKET IN FEED 148
TABLE 67 BENEFITS ASSOCIATED WITH ADMINISTRATION OF PROBIOTICS IN ANIMAL FEED 149
TABLE 68 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2020–2023 (USD BILLION) 149
TABLE 69 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2024–2029 (USD BILLION) 150
11 PROBIOTICS MARKET, BY REGION 151
11.1 INTRODUCTION 152
FIGURE 51 RAPIDLY GROWING MARKETS TO EMERGE AS NEW HOT SPOTS 152
TABLE 70 PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 153
TABLE 71 PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 153
TABLE 72 PROBIOTICS MARKET, BY REGION, 2020–2023 (KT) 153
TABLE 73 PROBIOTICS MARKET, BY REGION, 2024–2029 (KT) 154
11.2 NORTH AMERICA 154
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 154
FIGURE 52 NORTH AMERICA: INFLATION DATA, BY KEY COUNTRY, 2017–2022 155
FIGURE 53 NORTH AMERICA: RECESSION IMPACT ANALYSIS 156
TABLE 74 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 156
TABLE 75 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 156
TABLE 76 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 157
TABLE 77 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 157
TABLE 78 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 157
TABLE 79 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 157
TABLE 80 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 158
TABLE 81 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 158
TABLE 82 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 158
TABLE 83 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 159
TABLE 84 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 159
TABLE 85 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 159
TABLE 86 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 159
TABLE 87 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 160
11.2.2 US 160
11.2.2.1 Rise in digestive health awareness 160
TABLE 88 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 161
TABLE 89 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 161
11.2.3 CANADA 161
11.2.3.1 Demand for high-quality and innovative feed products to accelerate probiotics production and consumption 161
TABLE 90 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 162
TABLE 91 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 162
11.2.4 MEXICO 162
11.2.4.1 Consumer inclination toward healthy diets 162
TABLE 92 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 163
TABLE 93 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 163
11.3 EUROPE 163
FIGURE 54 EUROPE: MARKET SNAPSHOT 164
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 165
FIGURE 55 EUROPE: INFLATION DATA, BY KEY COUNTRY, 2017–2022 166
FIGURE 56 EUROPE: RECESSION IMPACT ANALYSIS 166
TABLE 94 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 167
TABLE 95 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 167
TABLE 96 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 167
TABLE 97 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 168
TABLE 98 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 168
TABLE 99 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 168
TABLE 100 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 169
TABLE 101 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 169
TABLE 102 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 169
TABLE 103 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 170
TABLE 104 EUROPE: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 170
TABLE 105 EUROPE: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 170
TABLE 106 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 170
TABLE 107 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 171
11.3.2 RUSSIA 171
11.3.2.1 Highly regulated probiotic landscape 171
TABLE 108 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 171
TABLE 109 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 172
11.3.3 UK 172
11.3.3.1 Shift toward natural foods that support digestive health 172
TABLE 110 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 173
TABLE 111 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 173
11.3.4 ITALY 173
11.3.4.1 Preference for cheese and awareness about health benefits of probiotics 173
TABLE 112 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 174
TABLE 113 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 174
11.3.5 GERMANY 174
11.3.5.1 Preference for probiotic yogurts and yogurt drinks and opportunity for use in poultry feed 174
TABLE 114 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 175
TABLE 115 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 175
11.3.6 SPAIN 175
11.3.6.1 Growing interest in health and wellness products among consumers to spur investment by companies 175
TABLE 116 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 176
TABLE 117 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 176
11.3.7 REST OF EUROPE 176
TABLE 118 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 177
TABLE 119 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 177
11.4 ASIA PACIFIC 177
FIGURE 57 ASIA PACIFIC: MARKET SNAPSHOT 178
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 179
FIGURE 58 ASIA PACIFIC: INFLATION DATA, BY KEY COUNTRY, 2017–2022 179
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 180
TABLE 120 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2020–2023 (USD BILLION) 180
TABLE 121 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2024–2029 (USD BILLION) 181
TABLE 122 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 181
TABLE 123 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 181
TABLE 124 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 181
TABLE 125 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 182
TABLE 126 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 182
TABLE 127 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 182
TABLE 128 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 183
TABLE 129 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 183
TABLE 130 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 183
TABLE 131 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 184
TABLE 132 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 184
TABLE 133 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 184
11.4.2 CHINA 184
11.4.2.1 Strategic moves by players to tap high sales potential of probiotics 184
TABLE 134 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 185
TABLE 135 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 185
11.4.3 JAPAN 186
11.4.3.1 Focus on digestive well-being of aging population 186
TABLE 136 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 186
TABLE 137 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 186
11.4.4 INDIA 187
11.4.4.1 Increased focus on women’s nutrition and post-COVID-19 consumer preference for functional food 187
TABLE 138 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 187
TABLE 139 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 187
11.4.5 AUSTRALIA & NEW ZEALAND 188
11.4.5.1 Aging population and consumer awareness to drive clinical trials and retail sales 188
TABLE 140 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 188
TABLE 141 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 188
11.4.6 REST OF ASIA PACIFIC 189
TABLE 142 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 189
TABLE 143 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 189
11.5 SOUTH AMERICA 190
11.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 190
FIGURE 60 SOUTH AMERICA: INFLATION DATA, BY COUNTRY, 2017–2022 191
FIGURE 61 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 191
TABLE 144 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 192
TABLE 145 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 192
TABLE 146 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 192
TABLE 147 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 193
TABLE 148 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 193
TABLE 149 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 193
TABLE 150 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 194
TABLE 151 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 194
TABLE 152 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 194
TABLE 153 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 195
TABLE 154 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 195
TABLE 155 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 195
TABLE 156 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 195
TABLE 157 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 196
11.5.2 BRAZIL 196
11.5.2.1 Rise in health awareness and meat exports to EU 196
TABLE 158 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 196
TABLE 159 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 197
11.5.3 ARGENTINA 197
11.5.3.1 Increase in industrialization of meat processing and dairy productivity 197
TABLE 160 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 198
TABLE 161 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 198
11.5.4 REST OF SOUTH AMERICA 198
TABLE 162 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 198
TABLE 163 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 199
11.6 REST OF THE WORLD (ROW) 199
11.6.1 ROW: RECESSION IMPACT ANALYSIS 199
FIGURE 62 ROW: INFLATION DATA, BY SUBREGION, 2017–2022 200
FIGURE 63 ROW: RECESSION IMPACT ANALYSIS 200
TABLE 164 ROW: PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 201
TABLE 165 ROW: PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 201
TABLE 166 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 201
TABLE 167 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 201
TABLE 168 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 202
TABLE 169 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 202
TABLE 170 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 202
TABLE 171 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 203
TABLE 172 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 203
TABLE 173 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 203
TABLE 174 ROW: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 204
TABLE 175 ROW: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 204
TABLE 176 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 204
TABLE 177 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 204
11.6.2 MIDDLE EAST 205
11.6.2.1 Demand for quality feed, high consumption of feed, and demand for yogurt 205
TABLE 178 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 205
TABLE 179 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 205
11.6.3 AFRICA 206
11.6.3.1 Investments in pharmaceutical companies to increase with intra-African trade 206
TABLE 180 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 206
TABLE 181 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 206
12 COMPETITIVE LANDSCAPE 207
12.1 OVERVIEW 207
12.2 SEGMENTAL REVENUE ANALYSIS 208
FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2018–2022 (USD BILLION) 208
12.3 MARKET SHARE ANALYSIS 209
TABLE 182 PROBIOTICS MARKET: DEGREE OF COMPETITION (COMPETITIVE) 209
12.4 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 210
TABLE 183 STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTICS MARKET 210
12.5 COMPANY VALUATION AND FINANCIAL METRICS 212
FIGURE 65 PROBIOTICS MARKET: COMPANY VALUATION (USD BILLION) 212
FIGURE 66 PROBIOTICS MARKET: EV/EBITDA, 2022 (USD BILLION) 212
12.6 BRAND/PRODUCT COMPARISON 213
FIGURE 67 PROBIOTICS MARKET: BRAND/PRODUCT COMPARISON 213
12.6.1 DIVERSE PROBIOTIC SOLUTIONS FUELING MARKET GROWTH 214
12.6.1.1 Nestlé Cerelac 214
12.6.1.2 Danone’s Activia 214
12.6.1.3 Yakult 214
12.6.1.4 LG21 by Meiji Holding Inc. 214
12.6.1.5 HOWARU by IFF Health 214
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 215
12.7.1 STARS 215
12.7.2 EMERGING LEADERS 215
12.7.3 PERVASIVE PLAYERS 215
12.7.4 PARTICIPANTS 216
FIGURE 68 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023 216
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS 217
12.7.5.1 Overall company footprint 217
FIGURE 69 PROBIOTICS MARKET: OVERALL COMPANY FOOTPRINT FOR KEY PLAYERS, 2023 217
12.7.5.2 Product type footprint 218
TABLE 184 PROBIOTICS MARKET: PRODUCT TYPE FOOTPRINT FOR KEY PLAYERS, 2023 218
12.7.5.3 End user footprint 218
TABLE 185 PROBIOTICS MARKET: END USER FOOTPRINT FOR KEY PLAYERS, 2023 218
12.7.5.4 Regional footprint 219
TABLE 186 PROBIOTICS MARKET: REGIONAL FOOTPRINT FOR KEY PLAYERS, 2023 219
12.8 COMPANY EVALUATION MATRIX: STARTUP/SMES 220
12.8.1 PROGRESSIVE COMPANIES 220
12.8.2 RESPONSIVE COMPANIES 220
12.8.3 DYNAMIC COMPANIES 220
12.8.4 STARTING BLOCKS 220
FIGURE 70 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2023 221
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES 222
12.8.5.1 Detailed list of key startup/smes 222
TABLE 187 PROBIOTICS MARKET: KEY STARTUP/SMES, 2023 222
12.8.5.2 Competitive benchmarking of key startup/smes 223
TABLE 188 PROBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 223
12.9 COMPETITIVE SCENARIO AND TRENDS 223
12.9.1 PRODUCT LAUNCHES 223
TABLE 189 PROBIOTICS MARKET: PRODUCT LAUNCHES, JANUARY 2019–FEBRUARY 2024 223
12.9.2 DEALS 227
TABLE 190 PROBIOTICS MARKET: DEALS, JANUARY 2019–FEBRUARY 2024 227
12.9.3 OTHERS 236
TABLE 191 PROBIOTICS MARKET: EXPANSIONS, JANUARY 2019–FEBRUARY 2024 236
TABLE 192 PROBIOTICS MARKET: OTHERS, JANUARY 2019–FEBRUARY 2024 239
13 COMPANY PROFILES 240
13.1 KEY PLAYERS 240
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 PROBI 240
TABLE 193 PROBI: BUSINESS OVERVIEW 240
FIGURE 71 PROBI: COMPANY SNAPSHOT 241
TABLE 194 PROBI: PRODUCTS/SOLUTIONS/SERVICES OFFERED 241
TABLE 195 PROBI: PRODUCT LAUNCHES 243
TABLE 196 PROBI: DEALS 243
13.1.2 NESTLÉ 246
TABLE 197 NESTLÉ: BUSINESS OVERVIEW 246
FIGURE 72 NESTLÉ: COMPANY SNAPSHOT 247
TABLE 198 NESTLÉ: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
TABLE 199 NESTLÉ: PRODUCT LAUNCHES 249
TABLE 200 NESTLÉ: DEALS 250
13.1.3 ADM 252
TABLE 201 ADM: BUSINESS OVERVIEW 252
FIGURE 73 ADM: COMPANY SNAPSHOT 253
TABLE 202 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 253
TABLE 203 ADM: DEALS 255
TABLE 204 ADM: EXPANSIONS 256
13.1.4 DANONE 258
TABLE 205 DANONE: BUSINESS OVERVIEW 258
FIGURE 74 DANONE: COMPANY SNAPSHOT 259
TABLE 206 DANONE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 259
TABLE 207 DANONE: PRODUCT LAUNCHES 260
TABLE 208 DANONE: EXPANSIONS 261
13.1.5 INTERNATIONAL FLAVORS & FRAGRANCES INC. 263
TABLE 209 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 263
FIGURE 75 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 264
TABLE 210 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 264
TABLE 211 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 265
TABLE 212 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS 266
13.1.6 YAKULT HONSHA CO., LTD. 268
TABLE 213 YAKULT HONSHA CO., LTD.: BUSINESS OVERVIEW 268
FIGURE 76 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT 269
TABLE 214 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
TABLE 215 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES 270
TABLE 216 YAKULT HONSHA CO., LTD.: DEALS 271
TABLE 217 YAKULT HONSHA CO., LTD.: EXPANSIONS 272
13.1.7 BIOGAIA 274
TABLE 218 BIOGAIA: BUSINESS OVERVIEW 274
FIGURE 77 BIOGAIA: COMPANY SNAPSHOT 275
TABLE 219 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 220 BIOGAIA: PRODUCT LAUNCHES 277
TABLE 221 BIOGAIA: DEALS 278
TABLE 222 BIOGAIA: EXPANSIONS 279
13.1.8 MORINAGA MILK INDUSTRY CO., LTD. 280
TABLE 223 MORINAGA MILK INDUSTRY CO., LTD.: BUSINESS OVERVIEW 280
FIGURE 78 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT 281
TABLE 224 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 225 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCT LAUNCHES 282
TABLE 226 MORINAGA MILK INDUSTRY CO., LTD.: OTHERS 283
TABLE 227 MORINAGA MILK INDUSTRY CO., LTD.: EXPANSIONS 284
13.1.9 MEIJI HOLDINGS CO., LTD. 286
TABLE 228 MEIJI HOLDINGS CO., LTD.: BUSINESS OVERVIEW 286
FIGURE 79 MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT 287
TABLE 229 MEIJI HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287
13.1.10 LIFEWAY FOODS, INC. 289
TABLE 230 LIFEWAY FOODS, INC.: BUSINESS OVERVIEW 289
FIGURE 80 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT 290
TABLE 231 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
TABLE 232 LIFEWAY FOODS, INC.: DEALS 295
13.1.11 ADISSEO 297
TABLE 233 ADISSEO: BUSINESS OVERVIEW 297
FIGURE 81 ADISSEO: COMPANY SNAPSHOT 298
TABLE 234 ADISSEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 298
13.1.12 WINCLOVE PROBIOTICS 300
TABLE 235 WINCLOVE PROBIOTICS: BUSINESS OVERVIEW 300
TABLE 236 WINCLOVE PROBIOTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300
TABLE 237 WINCLOVE PROBIOTICS: DEALS 302
TABLE 238 WINCLOVE PROBIOTICS: EXPANSIONS 302
13.1.13 AB-BIOTICS, S.A. 304
TABLE 239 AB-BIOTICS, S.A.: BUSINESS OVERVIEW 304
TABLE 240 AB-BIOTICS, S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304
TABLE 241 AB-BIOTICS, S.A.: DEALS 306
13.1.14 APSEN FARMACÊUTICA 308
TABLE 242 APSEN FARMACÊUTICA: BUSINESS OVERVIEW 308
TABLE 243 APSEN FARMACÊUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 308
TABLE 244 APSEN FARMACÊUTICA: PRODUCT LAUNCHES 309
TABLE 245 APSEN FARMACÊUTICA: DEALS 309
13.1.15 LALLEMAND 310
TABLE 246 LALLEMAND: BUSINESS OVERVIEW 310
TABLE 247 LALLEMAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 311
TABLE 248 LALLEMAND: DEALS 311
TABLE 249 LALLEMAND: EXPANSIONS 312
13.2 STARTUP/SME PLAYERS 314
13.2.1 ELANCO 314
TABLE 250 ELANCO: BUSINESS OVERVIEW 314
FIGURE 82 ELANCO: COMPANY SNAPSHOT 315
TABLE 251 ELANCO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 315
13.2.2 NEXTFOODS, INC. 317
TABLE 252 NEXTFOODS, INC.: BUSINESS OVERVIEW 317
TABLE 253 NEXTFOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 318
TABLE 254 NEXTFOODS, INC.: DEALS 319
13.2.3 I-HEALTH, INC. 321
TABLE 255 I-HEALTH, INC.: BUSINESS OVERVIEW 321
TABLE 256 I-HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 321
13.2.4 SUJA LIFE, LLC. 326
TABLE 257 SUJA LIFE, LLC.: BUSINESS OVERVIEW 326
TABLE 258 SUJA LIFE, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 326
TABLE 259 SUJA LIFE, LLC.: DEALS 327
13.2.5 RENEW LIFE FORMULAS, LLC 329
TABLE 260 RENEW LIFE FORMULAS, LLC.: BUSINESS OVERVIEW 329
TABLE 261 RENEW LIFE FORMULAS, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 330
13.2.6 BIOHM HEALTH 333
TABLE 262 BIOHM HEALTH: BUSINESS OVERVIEW 333
13.2.7 SUN GENOMICS 334
TABLE 263 SUN GENOMICS: BUSINESS OVERVIEW 334
13.2.8 UNIQUE BIOTECH LTD 335
TABLE 264 UNIQUE BIOTECH LTD: BUSINESS OVERVIEW 335
13.2.9 SO GOOD SO YOU 336
TABLE 265 SO GOOD SO YOU: BUSINESS OVERVIEW 336
13.2.10 PROTOCOL FOR LIFE BALANCE 337
TABLE 266 PROTOCOL FOR LIFE BALANCE: BUSINESS OVERVIEW 337
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 ADJACENT AND RELATED MARKETS 338
14.1 INTRODUCTION 338
TABLE 267 ADJACENT MARKETS TO PROBIOTICS 338
14.2 RESEARCH LIMITATIONS 338
14.3 DIETARY SUPPLEMENT MARKET 338
14.3.1 MARKET DEFINITION 338
14.3.2 MARKET OVERVIEW 338
TABLE 268 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 339
TABLE 269 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2023–2028 (USD MILLION) 340
14.4 BONE & JOINT HEALTH SUPPLEMENTS MARKET 340
14.4.1 MARKET DEFINITION 340
14.4.2 MARKET OVERVIEW 340
TABLE 270 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 341
TABLE 271 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 341
15 APPENDIX 342
15.1 DISCUSSION GUIDE 342
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 348
15.3 CUSTOMIZATION OPTIONS 350
15.4 RELATED REPORTS 350
15.5 AUTHOR DETAILS 351
Table of Contents